Granulomatosis with polyangiitis (GPA)
Board exam relevance: in 6 of more than 100 exam reports · rank 59- Synonyms
- Wegener granulomatosis, ANCA vasculitis, c-ANCA, PR3-ANCA, saddle nose
- Specialty
- Internal medicine · Rheumatology & immunology
- Images
- X-ray 1 · Histology 1 · Gross specimen 1 · Blood smear & cytology 1
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (4)
X-ray
Histology
Gross specimen
Blood smear & cytologyDefinition
Granulomatosis with polyangiitis (GPA, formerly Wegener granulomatosis) is an ANCA-associated vasculitis with necrotizing granulomatous inflammation, vasculitis of small and medium-sized vessels, and focal necrotizing, often crescentic glomerulonephritis. Involvement of the upper and lower respiratory tract and kidneys is typical; in principle, any organ may be affected.
Classification
In the 2012 Chapel Hill nomenclature, GPA, together with microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis, belongs to the ANCA-associated small-vessel vasculitides. The 2022 ACR/EULAR classification criteria assign positive or negative points to clinical, laboratory, biopsy, and imaging features and thereby distinguish GPA, MPA, and EGPA. Typical GPA features in these criteria are nasal involvement, cartilaginous involvement, PR3 or c-ANCA, granulomas or giant cells on biopsy, pulmonary nodules or cavities, and sinusitis on imaging.
Occurrence & epidemiology
Incidence varies by population; a large UK cohort found 11.8 per million person-years. GPA is most common in people of European ancestry but occurs in all ethnic groups and at any age. The mean age at onset is 40 years.
Aetiopathogenesis
It is an autoimmune disease with antibodies against proteinase 3 (PR3) in the cytoplasm of neutrophils. Inflammation affects tissues as well as vessels; the vasculitic component may be small or large. Early micronecrosis with neutrophils (microabscesses) progresses to larger, geographic necrosis.
Clinical features
Onset is insidious or acute; respiratory symptoms often predominate initially, and the kidney is affected later.
- Upper respiratory tract: sinus pain, serosanguineous or purulent nasal discharge, epistaxis, crusts, ulcers, septal perforation, saddle nose, subglottic stenosis with hoarseness and stridor.
- Ears: otitis, sensorineural hearing loss, vertigo.
- Eyes: conjunctivitis, scleritis, uveitis, retinal vasculitis, retro-orbital pseudotumor with proptosis and vision loss.
- Lower respiratory tract: nodules with or without cavitation, infiltrates, alveolar hemorrhage with hemoptysis.
- Kidney: glomerulonephritis up to the rapidly progressive form with hypertension and edema.
- Skin and nerves: palpable purpura, nodules, livedo, ulcers; mononeuritis multiplex, cranial nerve deficits.
- Myalgias, arthralgias, nonerosive arthritis; deep venous thrombosis during active disease.
Histology
Granulomas of histiocytic epithelioid cells, often with multinucleated giant cells, together with plasma cells, lymphocytes, neutrophils, and eosinophils. Central "geographic" necrosis is rimmed by lymphocytes, plasma cells, macrophages, and giant cells as well as palisading histiocytes. In the kidney, the most common finding is a pauci-immune, focal necrotizing glomerulonephritis with crescents.
Diagnosis
- Laboratory tests: ESR and CRP elevated, albumin and total protein decreased, sometimes anemia and thrombocytosis; creatinine, urinalysis with dysmorphic red cells and red cell casts, 24-hour urine protein.
- ANCA: immunofluorescence followed by ELISA; in active disease usually c-ANCA with antibodies against PR3. ANCA also occur in other conditions (e.g., endocarditis, cocaine use, lupus, tuberculosis); the positive predictive value is about 50 %.
- Imaging: sinonasal CT (mucosal thickening, septal perforation, bone destruction); chest CT, because radiographs may miss nodules and cavities.
- Biopsy of affected tissue confirms the diagnosis; lung tissue most likely shows the full picture, nasal biopsies rarely. A pauci-immune necrotizing glomerulonephritis on renal biopsy supports the diagnosis. Infections (mycobacteria, fungi) are excluded by stains and cultures.
Treatment principles
- Remission is induced with glucocorticoids combined with B-cell-depleting antibodies or an alkylating immunosuppressant; a C5a receptor antagonist can spare glucocorticoids, and plasma exchange is reserved for selected severe situations.
- After remission, long-term maintenance therapy follows, preferably B-cell-directed, with gradual tapering of glucocorticoids.
- Infection prophylaxis, vaccinations, osteoporosis prevention and management of organ damage to the kidneys, lungs and ear, nose and throat are also important.
Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.
Keep learning in the app
Further reading (open access)
- MSD Manual Professional: Granulomatosis with Polyangiitis (GPA)
- MSD Manual Professional: Overview of Vasculitis
- Performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for antineutrophil cytoplasmic antibody-associated vasculitis in previously diagnosed adult patients from Türkiye
- A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
Cross-references
More topics: Rheumatology & immunology
- Rheumatoid arthritis
- Systemic lupus erythematosus (SLE)
- Polymyalgia rheumatica
- Gout
- IgA vasculitis (Henoch-Schönlein purpura)
- Microscopic polyangiitis
- Mixed connective tissue disease (Sharp syndrome)
- Behçet's disease
- Polyarteritis nodosa
- Psoriatic arthritis
- Reactive arthritis
- Giant cell arteritis (temporal arteritis)
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.
Related pages: Rheumatoid arthritis · Systemic lupus erythematosus (SLE) · Polymyalgia rheumatica
Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.